9th Annual Biomarkers Congress
Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
Hilton Scottsdale Resort & Villas

Scottsdale, USA
http://www.fusion-conferences.com/conference2.php
Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
Fusion Conferences Ltd 
http://www.fusion-conferences.com/conference2.php
Hilton Scottsdale Resort & Villas
Scottsdale
USA

Schedule of Presentations:

Wednesday, October 16, 2013
05:15:00 Steve Young Retired VP Merck & Co
06:30:00 The Janssen Incubator – A Novel Business Model to Spark Internal Innovation
15:00:00 Registration & Reception
17:00:00 Opening Comments
17:15:00 Discovery Re-Invented
18:00:00 Drug Discovery – What really needs to be “Re-Invented”?
19:00:00 Group Dinner
20:00:00 Discovery of Eliquis®/Apixaban, a novel FXa anticoagulant Patrick Lam
20:00:00 Novel Pharma Approaches
20:30:00 Phenotypic Drug Discovery of Novel Anti-Angiogenics
21:00:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
21:30:00 Novel GyrB/ParE Inhibitors Michael Trzoss
Thursday, October 17, 2013
08:00:00 Collaborative Drug Discovery I
08:00:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Michael Foley
08:45:00 Associative Data Profiles Connect Basic Research to Translational Efforts Craig Thomas
09:15:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Todd Chappell
09:45:00 Genetics-Driven Psychiatry Drug Discovery James Barrow
10:15:00 Promoting Colorado Drug Discovery Research: Creation of the Colorado Center for Drug Discovery (C2D2)
10:30:00 Refreshments
11:00:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
11:30:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Zhengying Pan
12:00:00 Collaborative Drug Discovery Technology Neglected, Infectious, CNS, and Repositioning Applications Barry Bunin
12:15:00 Fertility reducing effect of pandanus candelabrum p.beauv. Leaves in male wistar rats
12:30:00 Free Time
16:30:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
16:30:00 Natural Products
16:45:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Sean Brady
17:30:00 Opportunities for Lead Discovery in a Biomedical Research Environment Jef De Brabander
18:00:00 A deep dive into aquatic microbial consortia for drug discovery
18:20:00 Non-competitive regulation of the human proteasome by natural products and natural product inspired scaffolds
18:45:00 Development of poppy varieties to suit changing market requirements
19:00:00 Group Dinner
20:00:00 Poster Session & Cocktail Reception
Friday, October 18, 2013
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
06:00:00 New Presentation
12:00:00 Group Lunch
12:45:00 Structure, Modelling & Informatics
12:45:00 Drug Discovery Accelerated by Computational Methods William L Jorgensen
13:30:00 Blurring to Bring Binding Free Energies into Focus Kenneth M Merz
14:00:00 Water Placement - Application of 3D-RISM to structure-based drug design Chris Williams
14:30:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
14:45:00 Quantum mechanics-based macromolecular x-ray refinement as an advanced method for the high throughput crystallography
15:00:00 Nimbus and Schrödinger Reinventing Drug Discovery: Rapid and Efficient Development of Acetyl-CoA Carboxylase Inhibitors
15:30:00 Compound Quality: What Have We Learned? Paul Gleeson
16:00:00 Refreshments
16:30:00 Biologics & Non-traditional Therapeutics Session Chair TBC
16:30:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits David Lowe
17:15:00 MRX34 – from bench to bedside Andreas Bader
17:45:00 Next Generation X-Aptamers for Personalized Nanomedicine David Gorenstein
18:15:00 Rapid Design and Production of Homogeneous Best-in-Class Protein Therapeutics using Cell-Free Protein Expression
18:45:00 Developing an Imaging Agent for Cholinesterase Enzymes to
19:00:00 Refreshments
19:30:00 Partnerships in drug discovery and development for diseases of the developing world Ken Duncan
19:30:00 Foundation Support for Neglected Diseases
20:30:00 Gala Night, Group Photo & Poster Awards
Saturday, October 19, 2013
09:00:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits
09:00:00 Discovery Technologies Session Chair TBC
09:20:00 RNAi mouse models: Revolutionizing drug discovery in vivo
09:40:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Erin M. Duffy
10:00:00 Finding and Applying Rules for Successful Drug Discovery Matthew Segall
10:30:00 Refreshments
11:00:00 Technology Transfer Re-invented: How is Academia Adapting to the Changes in Drug Discovery?
11:30:00 Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits Joel Dudley
12:00:00 Group Lunch
12:45:00 Drug Discovery in the Academic Community Benjamin Blass
12:45:00 Collaborative Drug Discovery II Bart DeCorte
13:15:00 Riluzole prodrugs for melanoma and ALS Mark McDonnell
13:45:00 Designing protein-protein interaction inhibitors as novel antimalarial chemotherapeutics Sandhya Kortagere
14:15:00 Synthesis of aminomethylthiazole analogues for evaluation as antiplasmodial agents
14:30:00 Discovery of Potent Macrocyclic Peptides for Drug Development
15:00:00 Closing Remarks (Chairs & Fusion)
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.